Watchdog approves Microlife buyout

IN AND OUTFLOWS: While one more Apple supplier invested in its China green fund, a local manufacturer’s China branch applied to invest in Taiwan due to the trade war

Taipei Times
Date: Sep 25, 2018
By: Ted Chen  /  Staff reporter

The Ministry of Economic Affairs’ Investment Commission on Friday last week approved a NT$9.35 billion (US$304.40 million) buyout of medical equipment maker Microlife Corp (百略) by an affiliate of Morgan Stanley Private Equity Asia.

Microlife in March announced that it had agreed to sell all of its shares to Midas Health Co Ltd at NT$84.74 per share, a 17.85 percent premium over the stock’s 20-day average closing price of NT$71.9.

The company is to be delisted from the local bourse next month, the commission said.

Midas Health is part of a US$1.7 billion closed-end private equity plan under Morgan Stanley.    [FULL  STORY]

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.